Clinical Trial Update: Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Kenya is investigating extended dosing intervals for an oral cholera vaccine and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Oral cholera vaccine

Snippet

Sponsor: Albert B. Sabin Vaccine Institute | Conditions: Cholera Vaccination | Phase 4 | Status: RECRUITING